Hims & Hers Health, Inc. Hims & Hers Health, Inc.

Hims & Hers Health, Inc.

HIMS

株式のランク #2842
Hims & Hers Health, Inc. operates a comprehensive digital health platform that... Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
株価
$29.14
時価総額
$6.55B
変化(1日)
3.52%
変化(1年)
-43.26%
国
US
取引 Hims & Hers Health, Inc. (HIMS)

カテゴリー

Healthcare
Hims & Hers Health, Inc.(HIMS)のP/E比率
October 2026 時点のP/E比率 TTM -45.44
Hims & Hers Health, Inc. の最新の財務報告および株価によると、現在の P/E (TTM) は -45.44 です。2023 年末時点での P/E は -79.13 でした。
Hims & Hers Health, Inc. の P/E 比率の履歴(2019 〜 2026)
各年末のP/E比率
年 P/E比率 変化
2026 (TTM) -45.44 -209.69%
2024 41.43 -152.35%
2023 -79.13 296.43%
2022 -19.96 75.65%
2021 -11.36 -60.12%
2020 -28.50 496.75%
2019 -4.78 0.00%
類似企業や競合他社のP/E比率
P/E比率の読み方

株価収益率(P/E Ratio)は、企業の株価と1株あたり利益の関係を示します。
低いが正のP/Eは、現在の評価額に対して高い利益を上げている企業を示し、割安と見なされる可能性があります。高い負の(0に近い)P/Eは、損失が大きいことを示します。

P/Eが30を超えるか、負である企業は一般に「成長株」と見なされ、投資家は将来的な成長または黒字化を期待しています。

10未満の正のP/Eを持つ企業は一般に「割安株」と見なされ、既に収益性が高いが成長の余地は小さいと見なされます。